Celularity (CELU) Research & Development (2020 - 2025)

Celularity (CELU) has reported Research & Development for 6 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Research & Development fell 12.57% year-over-year to $3.3 million in Q4 2025; TTM through Dec 2025 was $15.0 million, a 13.58% decrease from a year earlier, with the FY2025 full-year figure at $15.0 million, down 13.58% from the prior year.
• Research & Development was $3.3 million for Q4 2025 at Celularity, down from $4.6 million in the prior quarter.
• Over five years, Research & Development peaked at $25.3 million in Q2 2022 and troughed at -$272000.0 in Q4 2023.
• A 5-year average of $11.5 million and a median of $7.2 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slumped 102.47% in 2023 and jumped 1507.35% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $24.7 million in 2021, then sank by 55.48% to $11.0 million in 2022, then sank by 102.47% to -$272000.0 in 2023, then jumped by 1507.35% to $3.8 million in 2024, then slipped by 12.57% to $3.3 million in 2025.
• The last three Research & Development figures came in at $3.3 million (Q4 2025), $4.6 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.